Cargando…

Targeting Chromatin-Remodeling Factors in Cancer Cells: Promising Molecules in Cancer Therapy

ATP-dependent chromatin-remodeling complexes can reorganize and remodel chromatin and thereby act as important regulator in various cellular processes. Based on considerable studies over the past two decades, it has been confirmed that the abnormal function of chromatin remodeling plays a pivotal ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fang-Lin, Li, Da-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655648/ https://www.ncbi.nlm.nih.gov/pubmed/36361605 http://dx.doi.org/10.3390/ijms232112815

Ejemplares similares

Targeting Chromatin Remodeling for Cancer Therapy
por: Kaur, Jasmine, et al.
Publicado: (2019)

Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
por: Jiang, Dongfang, et al.
Publicado: (2023)

Sophisticated Conversations between Chromatin and Chromatin Remodelers, and Dissonances in Cancer
por: Clapier, Cedric R.
Publicado: (2021)

Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
por: Hojjat-Farsangi, Mohammad
Publicado: (2014)

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer
por: Pang, Ying, et al.
Publicado: (2023)

Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
por: Wanior, Marek, et al.
Publicado: (2021)

The emerging role of ISWI chromatin remodeling complexes in cancer
por: Li, Yanan, et al.
Publicado: (2021)

Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex‐deficient cancers
por: Sasaki, Mariko, et al.
Publicado: (2020)

Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer
por: Dandash, Fatima, et al.
Publicado: (2021)

Eukaryotic translation initiation factors as promising targets in cancer therapy
por: Hao, Peiqi, et al.
Publicado: (2020)

Neoantigens: promising targets for cancer therapy
por: Xie, Na, et al.
Publicado: (2023)

The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer
por: Vaicekauskaitė, Ieva, et al.
Publicado: (2022)

Chromatin-regulating proteins as targets for cancer therapy
por: Oike, Takahiro, et al.
Publicado: (2014)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)

Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer
por: Tang, Yanyan, et al.
Publicado: (2017)

Chromatin remodeling in oligodendrogenesis
por: Antontseva, E.V., et al.
Publicado: (2021)

DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics
por: Bhattacharjee, Dipanjan, et al.
Publicado: (2016)

Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
por: Krishnamurthy, Nithya, et al.
Publicado: (2022)

Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer
por: Chutani, Namita, et al.
Publicado: (2023)

Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy
por: Shi, Yijiang, et al.
Publicado: (2023)

Targeting DNA Repair and Chromatin Crosstalk in Cancer Therapy
por: Johnson, Danielle P., et al.
Publicado: (2021)

Single-molecule imaging of chromatin remodelers reveals role of ATPase in promoting fast kinetics of target search and dissociation from chromatin
por: Kim, Jee Min, et al.
Publicado: (2021)

Promising Nanomedicines of Shikonin for Cancer Therapy
por: Yan, Chunmei, et al.
Publicado: (2023)

Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015)

Chromatin remodelling comes into focus
por: Sundaramoorthy, Ramasubramian, et al.
Publicado: (2020)

Roles of Chromatin Remodelling and Molecular Heterogeneity in Therapy Resistance in Glioblastoma
por: Chen, Huey-Miin, et al.
Publicado: (2022)

DNA looping-dependent targeting of a chromatin remodeling factor
por: Yadon, Adam N., et al.
Publicado: (2013)

Promising molecular targeted therapies in breast cancer
por: Munagala, Radha, et al.
Publicado: (2011)

Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
por: An, Sainan, et al.
Publicado: (2018)

The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer
por: Hasan, Nesrin, et al.
Publicado: (2019)

Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy
por: Miyoshi, Eiji, et al.
Publicado: (2012)

G-quadruplexes: a promising target for cancer therapy
por: Kosiol, Nils, et al.
Publicado: (2021)

The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
por: Navickas, Sophie M., et al.
Publicado: (2023)

Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer
por: Luo, Youli, et al.
Publicado: (2021)

MicroRNA-7: a promising new target in cancer therapy
por: Zhao, Juanjuan, et al.
Publicado: (2015)

Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
por: Yang, Wenwei, et al.
Publicado: (2021)

Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy
por: Li, Yi, et al.
Publicado: (2023)

Chromatin Remodelers: From Function to Dysfunction
por: Längst, Gernot, et al.
Publicado: (2015)

Genetic Instability and Chromatin Remodeling in Spermatids
por: Cavé, Tiphanie, et al.
Publicado: (2019)

Protein arginine methyltransferases: promising targets for cancer therapy
por: Hwang, Jee Won, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h3bt2vbmgqrvhr2t6dlvq28osf